Literature DB >> 17701883

Effects of short-term propylthiouracil treatment on p wave duration and p wave dispersion in patients with overt hypertyroidism.

M T Katircibasi1, F Deniz, B Pamukcu, S Binici, I Atar.   

Abstract

BACKGROUND: P-wave duration is defined as the time measured from the onset to the offset of the P-wave in surface electrocardiogram (ECG). Prolonged P wave duration and increased P wave dispersion (PWD) have been reported to carry an increased risk for atrial fibrillation. AIM: Our aim was to evaluate the role of hyperthyroidism on P wave duration and dispersion, to investigate the effect of anti-thyroid therapy on P wave duration and dispersion.
MATERIAL AND METHODS: A total of 44 consecutive subjects (22 patients with newly diagnosed overt hyperthyroidism and 22 randomly selected euthyroid healthy subjects) were enrolled in the study. Transthoracic echocardiography, 12 lead surface ECG and thyroid hormone levels were studied at the time of enrollment, in the first and third months of the 6-8 mg/kg/day propylthiouracil therapy. Patients were followed-up for 3 months.
RESULTS: Patient and control groups were consisted of age and sex matched subjects. Baseline left atrial diameter was similar between the patient and control groups (3.4+/-0.3 cm and 3.4+/-0.3 cm respectively, p=0.813). The maximum P-wave duration (P maximum) was 113.1+/-6.6 and 105.7+/-4.1 ms in patient and control groups (p=0.001). PWD was 31.5+/-9.5 and 25.2+/-5.9 ms in patient and control groups respectively (p=0.015). At the third month of propylthiouracil treatment P maximum and PWD were decreased in the patient group at statistically significant level and returned back in normal limits (p<0.001 and p=0.001).
CONCLUSION: P wave duration and PWD are found prolonged in hyperthyroid patients and propylthiouracil treatment decreased them effectively. This mechanism may establish how the anti-thyroid treatment may prevent the development of atrial fibrillation in hyperthyroid patients.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17701883     DOI: 10.1055/s-2007-971066

Source DB:  PubMed          Journal:  Exp Clin Endocrinol Diabetes        ISSN: 0947-7349            Impact factor:   2.949


  6 in total

1.  Meta-analysis of p-wave dispersion values in healthy individuals: the influence of clinical characteristics.

Authors:  Udi Nussinovitch
Journal:  Ann Noninvasive Electrocardiol       Date:  2012-01       Impact factor: 1.468

2.  Celecoxib-induced change in atrial electrophysiologic substrate in arthritis patients.

Authors:  Katerina Pizzuto; Henry L Averns; Adrian Baranchuk; Hoshiar Abdollah; Kevin A Michael; Christopher Simpson; Damian P Redfearn
Journal:  Ann Noninvasive Electrocardiol       Date:  2013-09-24       Impact factor: 1.468

3.  P wave duration and dispersion in patients with hyperthyroidism and the short-term effects of antithyroid treatment.

Authors:  Unal Guntekin; Yilmaz Gunes; Hakki Simsek; Mustafa Tuncer; Sevket Arslan
Journal:  Indian Pacing Electrophysiol J       Date:  2009-09-01

Review 4.  P wave indices: current status and future directions in epidemiology, clinical, and research applications.

Authors:  Jared W Magnani; Mary Ann Williamson; Patrick T Ellinor; Kevin M Monahan; Emelia J Benjamin
Journal:  Circ Arrhythm Electrophysiol       Date:  2009-02

5.  Prolonged PR interval predicts clinical recurrence of atrial fibrillation after catheter ablation.

Authors:  Junbeom Park; Tae-Hoon Kim; Jihei Sara Lee; Jin Kyu Park; Jae Sun Uhm; Boyoung Joung; Moon Hyoung Lee; Hui-Nam Pak
Journal:  J Am Heart Assoc       Date:  2014-10-07       Impact factor: 5.501

Review 6.  Pro-Arrhythmic Signaling of Thyroid Hormones and Its Relevance in Subclinical Hyperthyroidism.

Authors:  Narcis Tribulova; Lin Hai Kurahara; Peter Hlivak; Katsuya Hirano; Barbara Szeiffova Bacova
Journal:  Int J Mol Sci       Date:  2020-04-19       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.